{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:21Z","timestamp":1793289561564,"version":"4.5.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1681\/asn.2009121291","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T22:41:30Z","timestamp":1272580890000},"page":"1052-1061","source":"Crossref","is-referenced-by-count":291,"title":["Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease"],"prefix":"10.1681","volume":"21","author":[{"given":"Marie C.","family":"Hogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana V.","family":"Masyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie J.","family":"Kubly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Bergstralh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard F.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Glockner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20230410","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"R2-23-20230410","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/316904","article-title":"Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2\u201313.1","volume":"67","author":"Reynolds","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R3-23-20230410","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1086\/368295","article-title":"Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease","volume":"72","author":"Li","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R4-23-20230410","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"R5-23-20230410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1104","article-title":"Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease","volume":"33","author":"Drenth","year":"2003","journal-title":"Nat Genet"},{"key":"R6-23-20230410","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: A critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg"},{"key":"R7-23-20230410","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: The last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"R8-23-20230410","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep.21143","article-title":"Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases","volume":"43","author":"Fabris","year":"2006","journal-title":"Hepatology"},{"key":"R9-23-20230410","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","author":"Qian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R10-23-20230410","doi-asserted-by":"crossref","first-page":"G890","DOI":"10.1152\/ajpgi.2001.280.5.G890","article-title":"MEK inhibits secretin release and pancreatic secretion: Roles of secretin-releasing peptide and somatostatin","volume":"280","author":"Li","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R11-23-20230410","doi-asserted-by":"crossref","first-page":"C1205","DOI":"10.1152\/ajpcell.00313.2002","article-title":"Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes","volume":"284","author":"Gong","year":"2003","journal-title":"Am J Physiol"},{"key":"R12-23-20230410","doi-asserted-by":"crossref","first-page":"15436","DOI":"10.1021\/bi00047a007","article-title":"Isolation and characterization of rat cholangiocyte vesicles enriched in apical or basolateral plasma membrane domains","volume":"34","author":"Tietz","year":"1995","journal-title":"Biochemistry"},{"key":"R13-23-20230410","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0928-4257(00)00206-0","article-title":"Signal transduction of somatostatin receptors negatively controlling cell proliferation","volume":"94","author":"Ferjoux","year":"2000","journal-title":"J Physiol Paris"},{"key":"R14-23-20230410","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1073\/pnas.77.8.4984","article-title":"Somatostatin: An endogenous peptide in the toad urinary bladder inhibits vasopressin-stimulated water flow","volume":"77","author":"Forrest","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-23-20230410","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0014-5793(86)81180-2","article-title":"Somatostatin and alpha 2-adrenergic agonists selectively inhibit vasopressin-induced cyclic AMP accumulation in MDCK cells","volume":"198","author":"Friedlander","year":"1986","journal-title":"FEBS Lett"},{"key":"R16-23-20230410","first-page":"8","article-title":"Effect of somatostatin on vasopressin-induced antidiuresis and renal cyclic AMP of rats","volume":"7","author":"Winkler","year":"1982","journal-title":"Miner Electrolyte Metab"},{"key":"R17-23-20230410","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1139\/y82-090","article-title":"Effect of somatostatin on renal water handling in the dog","volume":"60","author":"Mountokalakis","year":"1982","journal-title":"Can J Physiol Pharmacol"},{"key":"R18-23-20230410","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mce.2008.02.002","article-title":"Antitumor effects of somatostatin","volume":"286","author":"Pyronnet","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"R19-23-20230410","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"R20-23-20230410","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/gut.2008.155721","article-title":"Somatostatin analogues reduce liver volume in polycystic liver disease","volume":"57","author":"van Keimpema","year":"2008","journal-title":"Gut"},{"key":"R21-23-20230410","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"key":"R22-23-20230410","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1523-1755.2003.00242.x","article-title":"Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: A systems biology approach","volume":"64","author":"Grantham","year":"2003","journal-title":"Kidney Int"},{"key":"R23-23-20230410","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"R24-23-20230410","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"R25-23-20230410","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"R26-23-20230410","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R28-23-20230410","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/bmj.304.6842.1611","article-title":"Effects of long term octreotide on gall stone formation and gall bladder function","volume":"304","author":"Bigg-Wither","year":"1992","journal-title":"BMJ"},{"key":"R29-23-20230410","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2265.1998.00389.x","article-title":"Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly","volume":"48","author":"Davies","year":"1998","journal-title":"Clin Endocrinol"},{"key":"R30-23-20230410","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-112-3-173","article-title":"Therapeutic efficacy of the somatostatin analog SMS 201\u2013995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety","volume":"112","author":"Ho","year":"1990","journal-title":"Ann Intern Med"},{"key":"R31-23-20230410","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-115-11-913_1","article-title":"Octreotide and loss of scalp hair","volume":"115","author":"Jonsson","year":"1991","journal-title":"Ann Intern Med"},{"key":"R32-23-20230410","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00259-002-1050-8","article-title":"Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0), Tyr3]octreotate","volume":"30","author":"Kwekkeboom","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-23-20230410","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.2003.05478.x","article-title":"Hair loss in three patients with acromegaly treated with octreotide","volume":"149","author":"Lami","year":"2003","journal-title":"Br J Dermatol"},{"key":"R34-23-20230410","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1507\/endocrj.42.385","article-title":"Scalp hair loss caused by octreotide in a patient with acromegaly: A case report","volume":"42","author":"Nakauchi","year":"1995","journal-title":"Endocr J"},{"key":"R35-23-20230410","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1213\/01.ANE.0000097170.27056.08","article-title":"Octreotide-induced bradycardia and heart block during surgical resection of a carcinoid tumor","volume":"98","author":"Dilger","year":"2004","journal-title":"Anesth Analg"},{"key":"R36-23-20230410","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/j.1875-9114.1998.tb03872.x","article-title":"Octreotide-induced bradycardia","volume":"18","author":"Herrington","year":"1998","journal-title":"Pharmacotherapy"},{"key":"R37-23-20230410","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2165\/00003495-200868140-00003","article-title":"Use of somatostatin analogues in obesity","volume":"68","author":"Tzotzas","year":"2008","journal-title":"Drugs"},{"key":"R38-23-20230410","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2169\/internalmedicine.33.593","article-title":"Octreotide decreases biliary and pancreatic exocrine function, and induces steatorrhea in healthy subjects","volume":"33","author":"Nakamura","year":"1994","journal-title":"Intern Med"},{"key":"R39-23-20230410","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.juro.2007.01.146","article-title":"Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease","volume":"177","author":"Wagner","year":"2007","journal-title":"J Urol"},{"key":"R40-23-20230410","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/elps.1150181018","article-title":"Development of a nonisotopic capillary electrophoresis-based method for measuring glomerular filtration rate","volume":"18","author":"Bergert","year":"1997","journal-title":"Electrophoresis"},{"key":"R42-23-20230410","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF03168711","article-title":"New software toolkits for comprehensive visualization and analysis of three-dimensional multimodal biomedical images","volume":"10","author":"Hanson","year":"1997","journal-title":"J Digit Imaging"},{"key":"R43-23-20230410","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/bjr.73.871.11089458","article-title":"The benefit of stereology for quantitative radiology","volume":"73","author":"Roberts","year":"2000","journal-title":"Br J Radiol"},{"key":"R45-23-20230410","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease. [see comment]","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"R46-23-20230410","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R47-23-20230410","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0025-6196(12)65165-9","article-title":"Hepatic cysts in autosomal dominant polycystic kidney disease","volume":"65","author":"Everson","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"R48-23-20230410","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R49-23-20230410","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201006000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:32:30Z","timestamp":1786131150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201006000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2009121291","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}